Teacher Retirement System of Texas Has $40.20 Million Stock Holdings in CME Group Inc. (NASDAQ:CME)

Teacher Retirement System of Texas reduced its position in CME Group Inc. (NASDAQ:CME - Free Report) by 45.7% in the 1st quarter, according to its most recent filing with the SEC. The firm owned 151,536 shares of the financial services provider's stock after selling 127,526 shares during the period. Teacher Retirement System of Texas' holdings in CME Group were worth $40,201,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently made changes to their positions in the company. New Age Alpha Advisors LLC lifted its stake in shares of CME Group by 50.0% in the 4th quarter. New Age Alpha Advisors LLC now owns 129 shares of the financial services provider's stock valued at $30,000 after purchasing an additional 43 shares during the period. Golden State Wealth Management LLC increased its holdings in CME Group by 612.5% in the first quarter. Golden State Wealth Management LLC now owns 114 shares of the financial services provider's stock valued at $30,000 after purchasing an additional 98 shares during the last quarter. Alpine Bank Wealth Management acquired a new position in CME Group in the first quarter valued at about $32,000. Knuff & Co LLC bought a new position in CME Group during the fourth quarter worth about $33,000. Finally, Banque Transatlantique SA bought a new position in CME Group during the fourth quarter worth about $35,000. Institutional investors own 87.75% of the company's stock.

Analyst Ratings Changes

A number of analysts recently weighed in on the stock. Morgan Stanley increased their price target on shares of CME Group from $301.00 to $304.00 and gave the company an "overweight" rating in a research report on Thursday, April 24th. Citigroup lifted their price target on shares of CME Group from $265.00 to $275.00 and gave the stock a "neutral" rating in a research report on Thursday. JPMorgan Chase & Co. lowered their price objective on shares of CME Group from $223.00 to $211.00 and set an "underweight" rating for the company in a research report on Thursday, April 24th. UBS Group raised their price objective on CME Group from $290.00 to $305.00 and gave the stock a "buy" rating in a research note on Friday, April 25th. Finally, Royal Bank Of Canada reissued a "sector perform" rating and issued a $269.00 target price on shares of CME Group in a research note on Thursday, April 3rd. Three investment analysts have rated the stock with a sell rating, eight have given a hold rating and five have assigned a buy rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of "Hold" and an average target price of $259.87.

Insider Activity at CME Group

In related news, insider Derek Sammann sold 4,650 shares of the company's stock in a transaction dated Monday, May 5th. The stock was sold at an average price of $280.61, for a total transaction of $1,304,836.50. Following the sale, the insider owned 8,336 shares in the company, valued at $2,339,164.96. This represents a 35.81% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Dennis Suskind sold 1,000 shares of the stock in a transaction on Tuesday, April 29th. The stock was sold at an average price of $271.28, for a total value of $271,280.00. Following the completion of the transaction, the director owned 2,915 shares in the company, valued at approximately $790,781.20. This represents a 25.54% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 13,400 shares of company stock valued at $3,680,610 over the last ninety days. Insiders own 0.30% of the company's stock.

CME Group Stock Performance

NASDAQ:CME opened at $274.83 on Friday. CME Group Inc. has a twelve month low of $193.17 and a twelve month high of $290.79. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.13. The stock's 50-day simple moving average is $276.23 and its 200 day simple moving average is $257.62. The firm has a market capitalization of $99.04 billion, a PE ratio of 27.65, a price-to-earnings-growth ratio of 3.75 and a beta of 0.44.

CME Group (NASDAQ:CME - Get Free Report) last released its quarterly earnings data on Wednesday, April 23rd. The financial services provider reported $2.80 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $2.61 by $0.19. CME Group had a net margin of 57.71% and a return on equity of 14.03%. The business had revenue of $1.64 billion during the quarter, compared to analysts' expectations of $1.56 billion. During the same period in the prior year, the company earned $2.50 EPS. The firm's quarterly revenue was up 10.4% compared to the same quarter last year. On average, analysts anticipate that CME Group Inc. will post 10.49 EPS for the current fiscal year.

CME Group Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Wednesday, June 25th. Investors of record on Monday, June 9th were given a dividend of $1.25 per share. This represents a $5.00 annualized dividend and a yield of 1.82%. The ex-dividend date of this dividend was Monday, June 9th. CME Group's dividend payout ratio is currently 50.30%.

CME Group Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.